Terms: = Pancreatic cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Treatment
7 results:
1. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
2. SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer.
Botta GP; Kato S; Patel H; Fanta P; Lee S; Okamura R; Kurzrock R
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375311
[TBL] [Abstract] [Full Text] [Related]
3. Radiodynamic Therapy Using TAT Peptide-Targeted Verteporfin-Encapsulated PLGA Nanoparticles.
Clement S; Anwer AG; Pires L; Campbell J; Wilson BC; Goldys EM
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204001
[TBL] [Abstract] [Full Text] [Related]
4. Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis.
Gurusamy KS; Lusuku C; Halkias C; Davidson BR
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011521. PubMed ID: 26837472
[TBL] [Abstract] [Full Text] [Related]
5. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract] [Full Text] [Related]
6. Change in the growth rate of localized pancreatic adenocarcinoma in response to gemcitabine, bevacizumab, and radiation therapy on MDCT.
Rezai P; Yaghmai V; Tochetto SM; Galizia MS; Miller FH; Mulcahy MF; Small W
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):452-9. PubMed ID: 21570199
[TBL] [Abstract] [Full Text] [Related]
7. Plasma levels of pancreatic secretory trypsin inhibitor in relation to amylase and lipase in patients with acute and chronic renal failure.
Hörl WH; Wanner C; Schollmeyer P; Ogawa M
Nephron; 1988; 49(1):33-8. PubMed ID: 2454413
[TBL] [Abstract] [Full Text] [Related]
